{"disease":{"id":"autoimmune-lymphoproliferative-syndrome","name":"autoimmune lymphoproliferative syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06730126","title":"Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01672918","title":"Fluorodeoxyglucose Imaging Studies to Detect Lymphoma","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}